http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105769882-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14 |
| filingDate | 2016-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105769882-B |
| titleOfInvention | A kind of medical composition and its use of inhibition thrombosis |
| abstract | The invention discloses a kind of pharmaceutical composition of inhibition thrombosis, it includes a effective amount of aspirin of a) 1 compound of a effective amount of at least one formula, b)；The mass ratio of 1 compound of formula and aspirin is 1157:1~7:1.The pharmaceutical composition can be used for preparing the drug of antiplatelet drug and/or inhibition thrombosis.Research is found, choline and its derivative and aspirin have synergistic effect in terms of preventing or treating thrombus, cholinergic reduces the effective antithrombotic dosage of aspirin, aspirin dose only needs the 1/4 of former dosage, greatly reduce aspirin and prevents or treating the adverse reaction that may occur in thrombotic diseases, the compliance for improving patient's medication improves clinical application safety and curative effect, has good clinical use value and great Development volue. |
| priorityDate | 2016-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.